The fed­er­al gov­ern­ment has on­ly sent four ship­ments of Mer­ck’s Covid-19 an­tivi­ral mol­nupi­ravir (about 400,000 cours­es in each ship­ment) na­tion­wide, and al­ready HHS is re­port­ing … ...

Alex Gorsky, the CEO whose nine-year tenure at J&J was marred by law­suits over the com­pa­ny’s talc ba­by pow­der and opi­oids, will ...

When ac­tor Bel­lamy Young was grow­ing up, her fa­ther suf­fered from a brain dis­or­der called he­pat­ic en­cephalopa­thy (HE) caused by cir­rho­sis of the liv­er. … ...

PARIS — Last fall De­ci­phera suf­fered through a dis­as­trous set­back $DCPH with its lead drug, Qin­lock, which had been ap­proved as a fourth-line ther ...

In a sur­prise U-turn, the Biden ad­min­is­tra­tion said Wednes­day that it will sup­port a pro­pos­al at the World Trade Or­ga­ni­za­tion to tem­porar­i­ly waive in­tel­lec­tu­al prop­er­ty … ...

A bill that re­quires the Di­rec­tor of Na­tion­al In­tel­li­gence to de­clas­si­fy new in­for­ma­tion on the ori­gins of Covid-19 passed the House … ...

Months af­ter earn­ing its first ap­proval, Idor­sia is back with a Phase III win for a dif­fer­ent, J&J-part­nered drug.

Pfiz­er and Astel­las tout­ed more de­tailed da­ta over the week­end on their drug Xtan­di in a type of prostate can­cer, which the com­pa­nies say show … ...

HHS on Fri­day an­nounced its se­lec­tions for the next-gen­er­a­tion of Covid-19 vac­cine can­di­dates to re­ceive $500 mil­lion in fund­ing as part of the gov­ern­ment’s Project … ...

The EU is re­port­ed­ly work­ing to­ward a cen­tral­ized pro­cure­ment deal for small­pox vac­cines to tack­le the ris­ing num­ber of cas­es of mon­key­pox, ac­cord­ing to sources … ...

Gear­ing up for a bat­tle with phar­ma gi­ants, TG Ther­a­peu­tics says it’s near­ly ready to ap­proach reg­u­la­tors with its CD20 drug for mul­ti­ple scle­ro­sis … ...

The Fed­er­al Trade Com­mis­sion wants more in­for­ma­tion on Pfiz­er’s takeover of Seagen be­fore it will make a rul­ing on whether it will clear the … ...